gene therapy: be administered to patient

Related concepts

Parents	treatment Weight: 0.72 , chemotherapy Weight: 0.66 , field Weight: 0.64 , approach Weight: 0.64 , application Weight: 0.63
Siblings	acupuncture Weight: 0.35 , stimulation Weight: 0.35 , medication Weight: 0.35 , ablation Weight: 0.34 , corticosteroid Weight: 0.34

Related properties

Property	Similarity
be administered to patient	1.00
be administered	0.90
is administered	0.90
be administered to lymphoma patient	0.89
be administered intravenously	0.84
be administered in cycles	0.82
be used in patients	0.81
be given to patients	0.81
is administered nasally	0.77
is prescribed	0.76

Priors about this statement

Cues

Evidence

Clauses

Plausibility inference from child typicality

0.56

Rule weight: 0.66
Evidence weight: 0.95
Similarity weight: 0.89

Evidence: 0.80

Plausible(chemotherapy, be administered to lymphoma patient) ⋁

Evidence: 0.27

¬ Typical(gene therapy, be administered to patient)

0.48

Rule weight: 0.66
Evidence weight: 0.79
Similarity weight: 0.90

Evidence: 0.22

Plausible(chemotherapy, is administered) ⋁

Evidence: 0.27

¬ Typical(gene therapy, be administered to patient)

0.47

Rule weight: 0.66
Evidence weight: 0.79
Similarity weight: 0.90

Evidence: 0.21

Plausible(chemotherapy, be administered) ⋁

Evidence: 0.27

¬ Typical(gene therapy, be administered to patient)

0.42

Rule weight: 0.66
Evidence weight: 0.77
Similarity weight: 0.82

Evidence: 0.14

Plausible(chemotherapy, be administered in cycles) ⋁

Evidence: 0.27

¬ Typical(gene therapy, be administered to patient)

Plausibility inheritance from parent to child

0.07

Rule weight: 0.09
Evidence weight: 0.87
Similarity weight: 0.90

Evidence: 0.38

Plausible(gene therapy, be administered to patient) ⋁

Evidence: 0.21

¬ Plausible(chemotherapy, be administered)

0.07

Rule weight: 0.09
Evidence weight: 0.86
Similarity weight: 0.90

Evidence: 0.38

Plausible(gene therapy, be administered to patient) ⋁

Evidence: 0.22

¬ Plausible(chemotherapy, is administered)

0.07

Rule weight: 0.09
Evidence weight: 0.91
Similarity weight: 0.82

Evidence: 0.38

Plausible(gene therapy, be administered to patient) ⋁

Evidence: 0.14

¬ Plausible(chemotherapy, be administered in cycles)

0.04

Rule weight: 0.09
Evidence weight: 0.51
Similarity weight: 0.89

Evidence: 0.38

Plausible(gene therapy, be administered to patient) ⋁

Evidence: 0.80

¬ Plausible(chemotherapy, be administered to lymphoma patient)

Remarkability exclusitivity betweem a parent and a child

0.34

Rule weight: 0.58
Evidence weight: 0.73
Similarity weight: 0.82

Evidence: 0.81

¬ Remarkable(gene therapy, be administered to patient) ⋁

Evidence: 0.34

¬ Remarkable(chemotherapy, be administered in cycles)

0.23

Rule weight: 0.58
Evidence weight: 0.45
Similarity weight: 0.89

Evidence: 0.81

¬ Remarkable(gene therapy, be administered to patient) ⋁

Evidence: 0.68

¬ Remarkable(chemotherapy, be administered to lymphoma patient)

0.15

Rule weight: 0.58
Evidence weight: 0.30
Similarity weight: 0.90

Evidence: 0.81

¬ Remarkable(gene therapy, be administered to patient) ⋁

Evidence: 0.87

¬ Remarkable(chemotherapy, be administered)

0.12

Rule weight: 0.58
Evidence weight: 0.24
Similarity weight: 0.90

Evidence: 0.81

¬ Remarkable(gene therapy, be administered to patient) ⋁

Evidence: 0.95

¬ Remarkable(chemotherapy, is administered)

Remarkability exclusitivity between siblings

0.07

Rule weight: 0.13
Evidence weight: 0.61
Similarity weight: 0.81

Evidence: 0.81

¬ Remarkable(gene therapy, be administered to patient) ⋁

Evidence: 0.49

¬ Remarkable(corticosteroid, be given to patients)

0.05

Rule weight: 0.13
Evidence weight: 0.47
Similarity weight: 0.81

Evidence: 0.81

¬ Remarkable(gene therapy, be administered to patient) ⋁

Evidence: 0.65

¬ Remarkable(corticosteroid, be used in patients)

0.03

Rule weight: 0.13
Evidence weight: 0.31
Similarity weight: 0.84

Evidence: 0.81

¬ Remarkable(gene therapy, be administered to patient) ⋁

Evidence: 0.86

¬ Remarkable(medication, be administered intravenously)

0.03

Rule weight: 0.13
Evidence weight: 0.29
Similarity weight: 0.76

Evidence: 0.81

¬ Remarkable(gene therapy, be administered to patient) ⋁

Evidence: 0.88

¬ Remarkable(corticosteroid, is prescribed)

0.02

Rule weight: 0.13
Evidence weight: 0.22
Similarity weight: 0.76

Evidence: 0.81

¬ Remarkable(gene therapy, be administered to patient) ⋁

Evidence: 0.97

¬ Remarkable(medication, is prescribed)

Remarkability from parent implausibility

0.37

Rule weight: 0.42
Evidence weight: 0.98
Similarity weight: 0.89

Evidence: 0.80

Plausible(chemotherapy, be administered to lymphoma patient) ⋁

Evidence: 0.81

Remarkable(gene therapy, be administered to patient) ⋁

Evidence: 0.38

¬ Plausible(gene therapy, be administered to patient)

0.36

Rule weight: 0.42
Evidence weight: 0.94
Similarity weight: 0.90

Evidence: 0.21

Plausible(chemotherapy, be administered) ⋁

Evidence: 0.81

Remarkable(gene therapy, be administered to patient) ⋁

Evidence: 0.38

¬ Plausible(gene therapy, be administered to patient)

0.36

Rule weight: 0.42
Evidence weight: 0.94
Similarity weight: 0.90

Evidence: 0.22

Plausible(chemotherapy, is administered) ⋁

Evidence: 0.81

Remarkable(gene therapy, be administered to patient) ⋁

Evidence: 0.38

¬ Plausible(gene therapy, be administered to patient)

0.32

Rule weight: 0.42
Evidence weight: 0.94
Similarity weight: 0.82

Evidence: 0.14

Plausible(chemotherapy, be administered in cycles) ⋁

Evidence: 0.81

Remarkable(gene therapy, be administered to patient) ⋁

Evidence: 0.38

¬ Plausible(gene therapy, be administered to patient)

Remarkability from sibling implausibility

0.48

Rule weight: 0.60
Evidence weight: 0.96
Similarity weight: 0.84

Evidence: 0.38

Plausible(gene therapy, be administered to patient) ⋁

Evidence: 0.86

Remarkable(medication, be administered intravenously) ⋁

Evidence: 0.49

¬ Plausible(medication, be administered intravenously)

0.45

Rule weight: 0.60
Evidence weight: 0.99
Similarity weight: 0.76

Evidence: 0.38

Plausible(gene therapy, be administered to patient) ⋁

Evidence: 0.97

Remarkable(medication, is prescribed) ⋁

Evidence: 0.25

¬ Plausible(medication, is prescribed)

0.44

Rule weight: 0.60
Evidence weight: 0.97
Similarity weight: 0.76

Evidence: 0.38

Plausible(gene therapy, be administered to patient) ⋁

Evidence: 0.88

Remarkable(corticosteroid, is prescribed) ⋁

Evidence: 0.44

¬ Plausible(corticosteroid, is prescribed)

0.44

Rule weight: 0.60
Evidence weight: 0.90
Similarity weight: 0.81

Evidence: 0.38

Plausible(gene therapy, be administered to patient) ⋁

Evidence: 0.65

Remarkable(corticosteroid, be used in patients) ⋁

Evidence: 0.45

¬ Plausible(corticosteroid, be used in patients)

0.38

Rule weight: 0.60
Evidence weight: 0.79
Similarity weight: 0.81

Evidence: 0.38

Plausible(gene therapy, be administered to patient) ⋁

Evidence: 0.49

Remarkable(corticosteroid, be given to patients) ⋁

Evidence: 0.67

¬ Plausible(corticosteroid, be given to patients)

Salient implies Plausible

0.19

Rule weight: 0.28
Evidence weight: 0.68
Similarity weight: 1.00

Evidence: 0.38

Plausible(gene therapy, be administered to patient) ⋁

Evidence: 0.52

¬ Salient(gene therapy, be administered to patient)

Typical and Remarkable implies Salient

0.12

Rule weight: 0.14
Evidence weight: 0.90
Similarity weight: 1.00

Evidence: 0.52

Salient(gene therapy, be administered to patient) ⋁

Evidence: 0.27

¬ Typical(gene therapy, be administered to patient) ⋁

Evidence: 0.81

¬ Remarkable(gene therapy, be administered to patient)

Typical implies Plausible

0.40

Rule weight: 0.48
Evidence weight: 0.84
Similarity weight: 1.00

Evidence: 0.38

Plausible(gene therapy, be administered to patient) ⋁

Evidence: 0.27

¬ Typical(gene therapy, be administered to patient)

Typicality and Rermarkability incompatibility between a parent and a child

0.44

Rule weight: 0.51
Evidence weight: 0.97
Similarity weight: 0.90

Evidence: 0.81

¬ Remarkable(gene therapy, be administered to patient) ⋁

Evidence: 0.04

¬ Typical(chemotherapy, is administered)

0.44

Rule weight: 0.51
Evidence weight: 0.95
Similarity weight: 0.90

Evidence: 0.81

¬ Remarkable(gene therapy, be administered to patient) ⋁

Evidence: 0.07

¬ Typical(chemotherapy, be administered)

0.35

Rule weight: 0.51
Evidence weight: 0.84
Similarity weight: 0.82

Evidence: 0.81

¬ Remarkable(gene therapy, be administered to patient) ⋁

Evidence: 0.20

¬ Typical(chemotherapy, be administered in cycles)

0.15

Rule weight: 0.51
Evidence weight: 0.33
Similarity weight: 0.89

Evidence: 0.81

¬ Remarkable(gene therapy, be administered to patient) ⋁

Evidence: 0.83

¬ Typical(chemotherapy, be administered to lymphoma patient)

Typicality and Rermarkability incompatibility between siblings

0.10

Rule weight: 0.14
Evidence weight: 0.96
Similarity weight: 0.76

Evidence: 0.81

¬ Remarkable(gene therapy, be administered to patient) ⋁

Evidence: 0.05

¬ Typical(medication, is prescribed)

0.08

Rule weight: 0.14
Evidence weight: 0.70
Similarity weight: 0.84

Evidence: 0.81

¬ Remarkable(gene therapy, be administered to patient) ⋁

Evidence: 0.37

¬ Typical(medication, be administered intravenously)

0.08

Rule weight: 0.14
Evidence weight: 0.77
Similarity weight: 0.76

Evidence: 0.81

¬ Remarkable(gene therapy, be administered to patient) ⋁

Evidence: 0.28

¬ Typical(corticosteroid, is prescribed)

0.07

Rule weight: 0.14
Evidence weight: 0.64
Similarity weight: 0.81

Evidence: 0.81

¬ Remarkable(gene therapy, be administered to patient) ⋁

Evidence: 0.45

¬ Typical(corticosteroid, be used in patients)

0.04

Rule weight: 0.14
Evidence weight: 0.39
Similarity weight: 0.81

Evidence: 0.81

¬ Remarkable(gene therapy, be administered to patient) ⋁

Evidence: 0.76

¬ Typical(corticosteroid, be given to patients)

Typicality inheritance from parent to child

0.42

Rule weight: 0.48
Evidence weight: 0.97
Similarity weight: 0.90

Evidence: 0.27

Typical(gene therapy, be administered to patient) ⋁

Evidence: 0.04

¬ Typical(chemotherapy, is administered)

0.42

Rule weight: 0.48
Evidence weight: 0.95
Similarity weight: 0.90

Evidence: 0.27

Typical(gene therapy, be administered to patient) ⋁

Evidence: 0.07

¬ Typical(chemotherapy, be administered)

0.34

Rule weight: 0.48
Evidence weight: 0.85
Similarity weight: 0.82

Evidence: 0.27

Typical(gene therapy, be administered to patient) ⋁

Evidence: 0.20

¬ Typical(chemotherapy, be administered in cycles)

0.17

Rule weight: 0.48
Evidence weight: 0.39
Similarity weight: 0.89

Evidence: 0.27

Typical(gene therapy, be administered to patient) ⋁

Evidence: 0.83

¬ Typical(chemotherapy, be administered to lymphoma patient)